pharmaceuticals-and-healthcare

Global Platinum based Cancer Drug Market Research Report 2018


Published On : Jul 2018

Category : Pharmaceutical

No. of Pages : 172 pages

  • $2900
  • $5800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the Platinum based Cancer Drug market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Platinum based Cancer Drug market by product type and applications/end industries.

In the last several years, global market of platinum based cancer drug developed smoothly, with an average growth rate of 4.29%. In 2017, global revenue of platinum based cancer drug is nearly 1285 M USD; the actual sales are about 27572 K units.


The major players in global Platinum based Cancer Drug market include
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals


Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Platinum based Cancer Drug in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East & Africa


On the basis of product, the Platinum based Cancer Drug market is primarily split into
Cisplatin
Oxaliplatin
Carboplatin
Other

On the basis on the end users/applications, this report covers
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Other




In the recent times, the global market for Global platinum based cancer drug market research report 2018 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global platinum based cancer drug market research report 2018 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global platinum based cancer drug market research report 2018 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global platinum based cancer drug market research report 2018 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global platinum based cancer drug market research report 2018 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global platinum based cancer drug market research report 2018, including the definition, classification, and industry chain structure of Global platinum based cancer drug market research report 2018, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global platinum based cancer drug market research report 2018.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global platinum based cancer drug market research report 2018 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global platinum based cancer drug market research report 2018, implemented in each of the geographical segments. The predominant applications of the Global platinum based cancer drug market research report 2018 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global platinum based cancer drug market research report 2018 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global platinum based cancer drug market research report 2018 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Platinum based Cancer Drug1
Table Global Platinum based Cancer Drug Sales (K Unit) Comparison by Types (2013-2025)1
Figure Global Platinum based Cancer Drug Sales Market Share by Types in 20172
Figure Product Picture of Cisplatin3
Figure Product Picture of Oxaliplatin3
Figure Product Picture of Carboplatin4
Table Global Platinum based Cancer Drug Sales (K Unit) Comparison by Applications (2013-2025)4
Figure Global Platinum based Cancer Drug Sales Market Share by Applications in 20175
Figure Colorectal Cancer Examples5
Figure Ovarian Cancer Examples6
Figure Lung Cancer Examples6
Table Global Platinum based Cancer Drug Market Size (M USD) Comparison by Regions (2013-2025)7
Figure North America Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)8
Figure Europe Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)9
Figure Asia-Pacific Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)10
Figure South America Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)11
Figure Middle East & Africa Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025)12
Figure Global Platinum based Cancer Drug Revenue (M USD) Status and Outlook (2013-2025)13
Figure Global Platinum based Cancer Drug Sales (K Unit) Status and Outlook (2013-2025)14
Table Global Platinum based Cancer Drug Sales (K Unit) of Key Manufacturers (2017-2018)15
Table Global Platinum based Cancer Drug Sales Market Share by Manufacturers (2017-2018)15
Figure 2017 Platinum based Cancer Drug Sales Market Share by Manufacturers16
Figure 2018 Platinum based Cancer Drug Sales Market Share by Manufacturers17
Table Global Platinum based Cancer Drug Revenue (M USD) by Manufacturers (2017-2018)17
Table Global Platinum based Cancer Drug Revenue Share by Manufacturers (2017-2018)18
Figure 2017 Global Platinum based Cancer Drug Revenue Share by Manufacturers19
Figure 2018 Global Platinum based Cancer Drug Revenue Share by Manufacturers20
Table Global Market Platinum based Cancer Drug Average Price (USD/Unit) of Key Manufacturers (2017-2018)20
Figure Global Market Platinum based Cancer Drug Average Price (USD/Unit) of Key Manufacturers in 201721
Table Manufacturers Platinum based Cancer Drug Headquarters and Established22
Figure 2017 Platinum based Cancer Drug Revenue Market Share by Manufacturers23
Figure 2017 Platinum based Cancer Drug Revenue Market Share of Top 3 Manufacturers24
Figure 2017 Platinum based Cancer Drug Revenue Market Share of Top 5 Manufacturers25
Table Global Platinum based Cancer Drug Sales (K Unit) by Regions (2013-2018)30
Table Global Platinum based Cancer Drug Sales Market Share by Regions (2013-2018)30
Figure Global Platinum based Cancer Drug Sales Market Share by Regions (2013-2018)31
Figure 2017 Global Platinum based Cancer Drug Sales Market Share by Regions31
Table Global Platinum based Cancer Drug Revenue (M USD) by Regions (2013-2018)32
Table Global Platinum based Cancer Drug Revenue Market Share by Regions (2013-2018)32
Figure Global Platinum based Cancer Drug Revenue Market Share by Regions (2013-2018)33
Figure 2017 Global Platinum based Cancer Drug Revenue Market Share by Regions34
Figure Global Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)35
Table Global Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)35
Figure North America Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)36
Table North America Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)36
Figure Europe Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)37
Table Europe Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)38
Figure Asia-Pacific Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)39
Table Asia-Pacific Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)39
Figure South America Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)40
Table South America Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)41
Figure Middle East & Africa Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018)42
Table Middle East & Africa Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018)43
Table Global Platinum based Cancer Drug Sales (K Unit) by Types (2013-2018)44
Table Global Platinum based Cancer Drug Sales Market Share by Types (2013-2018)44
Figure Sales Market Share of Platinum based Cancer Drug by Types (2013-2018)45
Figure 2017 Sales Market Share of Platinum based Cancer Drug by Types45
Table Global Platinum based Cancer Drug Revenue (M USD) by Types (2013-2018)46
Table Global Platinum based Cancer Drug Revenue Share by Types (2013-2018)46
Figure Revenue Share of Platinum based Cancer Drug by Types (2013-2018)47
Figure 2017 Revenue Market Share of Platinum based Cancer Drug by Types47
Table Global Platinum based Cancer Drug Price (USD/Unit) by Types (2013-2018)48
Figure Global Platinum based Cancer Drug Sales Growth Rate by Types (2013-2018)48
Table Global Platinum based Cancer Drug Sales (K Unit) by Applications (2013-2018)49
Table Global Platinum based Cancer Drug Sales Market Share by Applications (2013-2018)49
Figure Global Platinum based Cancer Drug Sales Market Share by Applications (2013-2018)50
Figure Global Platinum based Cancer Drug Sales Market Share by Applications in 201750
Figure Global Platinum based Cancer Drug Sales Growth Rate by Applications (2013-2018)51
Table Sanofi Company Profile52
Figure Platinum based Cancer Drug Product Picture of Sanofi53
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2017-201854
Table Hengrui Medicine Company Profile54
Figure Platinum based Cancer Drug Product Picture of Hengrui Medicine55
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Hengrui Medicine 2017-201856
Table ASK Pharma Company Profile56
Figure Platinum based Cancer Drug Product Picture of ASK Pharma57
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ASK Pharma 2017-201857
Table Yi Bai Pharmaceutical Company Profile58
Figure Platinum based Cancer Drug Product Picture of Yi Bai Pharmaceutical59
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Yi Bai Pharmaceutical 2017-201859
Table Qilu Pharmaceutical Company Profile60
Figure Platinum based Cancer Drug Product Picture of Qilu Pharmaceutical61
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Qilu Pharmaceutical 2017-201861
Table Teva Company Profile61
Figure Platinum based Cancer Drug Product Picture of Teva63
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2017-201863
Table Pfizer Company Profile64
Figure Platinum based Cancer Drug Product Picture of Pfizer65
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2017-201865
Table Dr Reddys Laboratories Company Profile66
Figure Platinum based Cancer Drug Product Picture of Dr Reddys Laboratories67
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Dr Reddys Laboratories 2017-201867
Table Mylan Company Profile68
Figure Platinum based Cancer Drug Product Picture of Mylan69
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2017-201869
Table Sun Pharma Company Profile70
Figure Platinum based Cancer Drug Product Picture of Sun Pharma71
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sun Pharma 2017-201871
Table Novartis Company Profile72
Figure Platinum based Cancer Drug Product Picture of Novartis73
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2017-201873
Table Debiopharm Company Profile74
Figure Platinum based Cancer Drug Product Picture of Debiopharm75
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Debiopharm 2017-201875
Table Accord Healthcare Company Profile76
Figure Platinum based Cancer Drug Product Picture of Accord Healthcare77
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Accord Healthcare 2017-201877
Table SK Chemicals Company Profile78
Figure Platinum based Cancer Drug Product Picture of SK Chemicals79
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of SK Chemicals 2017-201879
Figure typical phases from research to the market for a drug candidate81
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound82
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound83
Figure Manufacturing Cost Structure of Platinum based Cancer Drug83
Figure USA Labor Cost Analysis 2013-201884
Figure Cost of Employing a Factory Worker85
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe86
Figure Monthly Minimum Wages in Asia 201687
Figure China Labor Costs 2013-201687
Table Average Price of Electricity to Ultimate Customers 2007-201688
Figure Electricity Prices for Household Consumers in 201689
Figure Summary of the Driving Assumptions91
Figure Industrial Electric Rates 2016 (PER KWH)91
Figure Manufacturing Process Analysis of Platinum based Cancer Drug93
Figure Platinum based Cancer Drug Industrial Chain Analysis94
Table Major Buyers of Platinum based Cancer Drug95
Figure Marketing Channel for Biopharmaceuticals98
Figure Conceptual Model of the Flow of Products, Services and Funds for Non-specialty Drugs Coveredunder Private Insurance and Purchased in a Retail Setting99
Figure Marketing Channel for Biopharmaceuticals100
Figure Flow of US Prescription Sales Contribution by Channel101
Figure Setting Pricing Policy102
Table Distributors/Traders List104
Figure New Active Substance Launches 2011-2015 by Indication107
Figure Immuno-Oncology PD-1 Inhibitor Uptake in the U.S.108
Figure Growth of the Late Phase Oncology Pipeline, 2005-2015109
Figure Key In-Market and Investigational Agents for NSCLC110
Figure Key In-Market and Investigational Agents for Melanoma110
Figure the Global Late Phase Oncology Pipeline in 2015111
Figure Companies with Active Late Phase Oncology Pipelines112
Figure Cancer Incidence by Country in 2014114
Figure Cancer Mortality by Country in 2014114
Figure USA numbers of new cancer cases for 2015115
Figure Global GDP Growth Rate for 2016116
Figure Real GDP Growth 2016-2020 annual Average117
Figure USA GDP 2008-2016 (Billion USD)118
Figure USA GDP Growth Rate Change 2015-2018118
Figure EU GDP 2008-2016 (Billion USD)119
Figure EU GDP Growth Rate Change 2015-2018119
Figure Germany GDP 2008-2016 (Billion USD)120
Figure Germany GDP Growth Rate 2015-2018120
Figure UK GDP 2008-2016 (Billion USD)120
Figure UK GDP Growth Rate 2015-2018121
Figure Italy GDP 2008-2016 (Billion USD)121
Figure Italy GDP Growth Rate 2015-2018121
Figure France GDP 2008-2016 (Billion USD)122
Figure France GDP Growth Rate 2015-2018122
Figure Japan GDP 2008-2016 (Billion USD)122
Figure Japan GDP Growth Rate 2015-2018123
Figure China GDP 2008-2016 (Billion USD)123
Figure China GDP Growth Rate 2015-2018123
Figure Global Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)124
Figure Global Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)125
Figure Global Platinum based Cancer Drug Price (USD/Unit) Trend Forecast (2019-2025)126
Table Global Platinum based Cancer Drug Sales (K Unit) Forecast by Regions (2019-2025)126
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Regions (2019-2025)127
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Regions in 2025127
Figure North America Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)128
Figure North America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)129
Figure Europe Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)130
Figure Europe Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)131
Figure Asia-Pacific Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)132
Figure Asia-Pacific Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)133
Figure South America Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)134
Figure South America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)135
Figure Middle East & Africa Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025)136
Figure Middle East & Africa Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)137
Table Global Platinum based Cancer Drug Revenue (M USD) Forecast by Regions (2019-2025)137
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Regions (2019-2025)138
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Regions in 2025138
Figure North America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)139
Figure Europe Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)140
Figure Asia-Pacific Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)141
Figure South America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)142
Figure Middle East & Africa Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025)143
Table Global Platinum based Cancer Drug Sales (K Unit) Forecast by Types (2019-2025)143
Table Global Platinum based Cancer Drug Sales Market Share Forecast by Types (2019-2025)144
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Types (2019-2025)144
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Types in 2025145
Table Global Platinum based Cancer Drug Revenue (M USD) Forecast by Types (2019-2025)145
Table Global Platinum based Cancer Drug Revenue Market Share Forecast by Types (2019-2025)145
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Types (2019-2025)146
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Types in 2025147
Table Global Platinum based Cancer Drug Price (USD/Unit) Forecast by Types (2019-2025)147
Table Global Platinum based Cancer Drug Sales (K Unit) Forecast by Application (2019-2025)148
Table Global Platinum based Cancer Drug Sales Market Share Forecast by Application (2019-2025)148
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Application (2019-2025)149
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Application in 2025149

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top